Radnor Capital Management, LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 80 filers reported holding CYTOSORBENTS CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radnor Capital Management, LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2020$80,000
-20.0%
10,0000.0%0.03%
-25.0%
Q2 2020$100,000
+29.9%
10,0000.0%0.04%
+12.5%
Q1 2020$77,000
+97.4%
10,0000.0%0.03%
+166.7%
Q4 2019$39,000
-22.0%
10,0000.0%0.01%
-25.0%
Q3 2019$50,000
-24.2%
10,0000.0%0.02%
-27.3%
Q2 2019$66,000
-13.2%
10,0000.0%0.02%
-12.0%
Q1 2019$76,000
-6.2%
10,0000.0%0.02%
-13.8%
Q4 2018$81,000
-37.2%
10,0000.0%0.03%
-29.3%
Q3 2018$129,000
+13.2%
10,0000.0%0.04%
-2.4%
Q2 2018$114,000
+62.9%
10,0000.0%0.04%
+75.0%
Q1 2018$70,000
+7.7%
10,0000.0%0.02%
+14.3%
Q4 2017$65,00010,0000.02%
Other shareholders
CYTOSORBENTS CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 692,738$5,524,0002.01%
Skylands Capital, LLC 1,421,700$11,345,0001.89%
SECTORAL ASSET MANAGEMENT INC 1,629,989$12,999,0001.12%
Winning Points Advisors, LLC 286,200$1,142,990,0000.97%
Redmile Group, LLC 2,101,131$16,757,0000.31%
Granahan Investment Management 632,035$5,040,0000.17%
Avenir Corp 190,240$1,517,0000.16%
Seelaus Asset Management LLC 20,000$160,0000.13%
Olympiad Research LP 17,816$142,0000.07%
HighMark Wealth Management LLC 10,000$80,0000.07%
View complete list of CYTOSORBENTS CORP shareholders